Gemtesa 75 MG tablet 90S
Ended Awarded
- Contract number
- SPE2DB26FDQ95
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $23,962
Award facts
- Contract value 100% obligated
- $23,961.99 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $23,961.99 to AmerisourceBergen Drug Corp for Gemtesa 75 mg tablets (90-count supply) on October 16, 2025, with completion targeted for October 17, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the DLA's Medical Supply Chain.
This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. This prime indefinite delivery vehicle provides comprehensive global pharmaceutical support, enabling the contractor to supply a broad range of medications, vaccines, medical devices, and specialized healthcare commodities to support military healthcare programs worldwide. The contract reflects DLA's strategic approach to pharmaceutical procurement through vendor partnerships that ensure reliable access to both brand-name and generic medications across multiple therapeutic domains for defense and healthcare operations.
Quick answers
Who was awarded contract SPE2DB26FDQ95?
SPE2DB26FDQ95 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 16, 2025.
How much is contract SPE2DB26FDQ95 worth?
The government has obligated $23,962 on SPE2DB26FDQ95.
Is contract SPE2DB26FDQ95 an order under another contract?
Yes. SPE2DB26FDQ95 is a delivery order under SPE2DB22D2206, an indefinite delivery contract.
Was contract SPE2DB26FDQ95 competed?
The extent of competition for SPE2DB26FDQ95 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award